Robert Estey

CEO at Per Os Biosciences

Education

Colgate University

BA, Economics

Rochester Institute of Technology

MBA, Operations Research

Experience

Per Os Biosciences

CEO / June, 2016 — Present

Per Os Bio develops, manufactures and markets dietary supplement and functional food products in niche therapeutic categories. Per Os has four issued patents for its innovative gum manufacturing process and many patent applications under current review by USPTO. Per Os manufacturing capabilities include: - functional tableted chewing gum (the only manufacturer in the U.S.) - multi-patented process - lozenges (fast melt or slow dissolve) - chewable tablets (we created the Airborne chewable tablet) - pressed confectionery candy/mints Per Os has developed some very unique dietary supplement products which are one-of-a-kind in the market, including nitric oxide and hemp oil/cannabidiol (CBD) products. Per Os has patented technology to manufacture chewing gum and lozenges that incorporate any active ingredient, including CBD and THC. Per Os can custom formulate our tableted product dosage formats or provide a private-label of already developed gum and/or lozenge products.

Mastix Medica/Mastix LLC

Founder and CEO / February, 2009 — October, 2018

Mastix was created from the acquisition of a confectionery manufacturer with the strategy of transforming the business into a niche generic pharmaceutical company.

ANI Pharmaceuticals, Inc.

Co-Founder and Chief Busness Officer / March, 2004 — May, 2007

Xanodyne Pharmaceuticals

CFO / September, 2001 — April, 2004

Created the business infrastructure to produce and market pharmaceutical products purchased from a major pharmaceutical company. Merged the company with Integrity Pharmacuticals.

Alpharma

Vice President of Finance / March, 1999 — September, 2001

Turned around the company and changed the strategic direction. Led turnaround team that doubled sales and increased profits 5x within three years. Led $660 million strategic acquisition of Purepac Pharmaceuticals.

Florida Tile Industries

Vice President of Finance / August, 1994 — March, 1999

Turned around a four-year profit decline by reengineering all business and operational processes. Member of turnaround team that returned division to profitability within two years ($15 million profit improvement).

Earlier Companies

Financial & Operational Positions / January, 1981 — August, 1994

Increasingly responsible financial positions with Pfizer, Praxis Biologics, Lever Brothers, Pennwalt and Everest Healthcare

Join Bob on NotedSource!

Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.